Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD–diazepam interaction study in adults
ACTRN12624001021561Phase 2Not yet recruiting
- Sponsor
- The University of Sydney
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cannabidiol and diazepam in anxiety disorder (2 arms), sponsored by The University of Sydney. Primary endpoint: Area under the plasma diazepam concentration-time curve. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
cannabidioldiazepam
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on ACTRN12624001021561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624001021561.